US FDA Creating Rare Disease ‘Hub’ To Serve As Center Of Excellence

While not brandishing the name advocates have pushed for many years, the rare disease hub will play much the same role as a center of excellence in increasing collaboration between experts in the FDA drug and biologics centers.

rare disease
The CDER-CBER rare disease hub could begin emerging by the end of the year. • Source: Shutterstock

More from DIA

More from Conferences